LAWSON, John David,SABAT, Mark,SCORAH, Nicholas,SMITH, Christopher,VU, Phong H.
申请号：
TN2015000342
公开号：
TN2015000342A1
申请日:
2015.08.11
申请国别(地区):
TN
年份:
2017
代理人:
摘要：
Disclosed are compounds of Formula 1, or pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and R4 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating Type I hypersensitivity reactions, autoimmune diseases, inflammatory disorders, cancer, non-malignant proliferative disorders, and other conditions associated with BTK.
